Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neurofibrosarcoma × pexidartinib × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Giant Cell Tumor of Tendon Sheath 3 Triple Negative Breast Neoplasms 1 Synovitis, Pigmented Villonodular 1 Sarcoma 1 Pathologic Complete Response 1 Neurofibrosarcoma 1 Neoplasms 1 Melanoma 1 Hemangiosarcoma 1 Breast Neoplasms 1

Interventions

selinexor 3 Doxorubicin 3 pembrolizumab 2 pazopanib 2 fludarabine phosphate 2 Nivolumab 2 Magnetic Resonance Spectroscopy 2 Ifosfamide 2 AZD 6244 2 thymoglobulin 1 tazemetostat 1 sotigalimab 1 pexidartinib 1 metarrestin 1 fludarabine 1 decitabine and cedazuridine drug combination 1 Thiotepa 1 Tacrolimus 1 Stem Cell Transplantation 1 Specimen Handling 1 Sirolimus 1 Radiotherapy 1 Radiation 1 Proton Therapy 1 Mycophenolic Acid 1 Mesna 1 Melphalan 1 Liquid Biopsy 1 Ipilimumab 1 Etoposide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02584647 2025-03-21

PLX3397

Columbia University

Phase 1/2 Terminated

39 enrolled 13 charts

Sarcoma, Neurofibrosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡